Jennifer G Robinson
Jennifer G Robinson
Verified email at uiowa.edu
Title
Cited by
Cited by
Year
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
34221*2012
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 131 (4), e29-e322, 2015
165642015
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American …
NJ Stone, JG Robinson, AH Lichtenstein, CN Bairey Merz, CB Blum, ...
Journal of the American College of Cardiology 63 (25 Part B), 2889-2934, 2014
89452014
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network
Nature 455 (7216), 1061, 2008
56602008
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
DC Goff, DM Lloyd-Jones, G Bennett, S Coady, RB D’agostino, R Gibbons, ...
Journal of the American College of Cardiology 63 (25 Part B), 2935-2959, 2014
48782014
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events
JG Robinson, M Farnier, M Krempf, J Bergeron, G Luc, M Averna, ...
New England Journal of Medicine 372 (16), 1489-1499, 2015
19322015
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ...
New England Journal of Medicine 372 (16), 1500-1509, 2015
13632015
Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association
FM Sacks, AH Lichtenstein, JHY Wu, LJ Appel, MA Creager, ...
Circulation 136 (3), e1-e23, 2017
7812017
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on …
AC Goldberg, PN Hopkins, PP Toth, CM Ballantyne, DJ Rader, ...
Journal of clinical lipidology 5 (3), 133-140, 2011
7772011
Noninvasive pulse wave analysis for the early detection of vascular disease
JN Cohn, S Finkelstein, G McVeigh, D Morgan, L LeMay, J Robinson, ...
Hypertension 26 (3), 503-508, 1995
6781995
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
TG and HDL Working Group of the Exome Sequencing Project, National Heart ...
New England Journal of Medicine 371 (1), 22-31, 2014
5822014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ...
The Lancet 385 (9965), 351-361, 2015
5472015
Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis
JG Robinson, B Smith, N Maheshwari, H Schrott
Journal of the American College of Cardiology 46 (10), 1855-1862, 2005
5362005
Meta-analysis of the relationship between non–high-density lipoprotein cholesterol reduction and coronary heart disease risk
JG Robinson, S Wang, BJ Smith, TA Jacobson
Journal of the American College of Cardiology 53 (4), 316-322, 2009
5322009
Effect of evolocumab or ezetimibe added to moderate-or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical …
JG Robinson, BS Nedergaard, WJ Rogers, J Fialkow, JM Neutel, ...
Jama 311 (18), 1870-1883, 2014
5052014
CLINICAL PERSPECTIVE
HA Tindle, YF Chang, LH Kuller, JAE Manson, JG Robinson, MC Rosal, ...
Circulation 120 (8), 656-662, 2009
4922009
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
BA Ference, JG Robinson, RD Brook, AL Catapano, MJ Chapman, ...
New England Journal of Medicine 375 (22), 2144-2153, 2016
4742016
Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
MS Sabatine, RP Giugliano, SD Wiviott, FJ Raal, DJ Blom, J Robinson, ...
N Engl J Med 372 (16), 1500-1509, 2015
4112015
Cognitive function in a randomized trial of evolocumab
RP Giugliano, F Mach, K Zavitz, C Kurtz, K Im, E Kanevsky, J Schneider, ...
New England Journal of Medicine 377 (7), 633-643, 2017
3272017
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: the …
DJ Kereiakes, JG Robinson, CP Cannon, C Lorenzato, R Pordy, ...
American heart journal 169 (6), 906-915. e13, 2015
3152015
The system can't perform the operation now. Try again later.
Articles 1–20